-
-
28/05/2025 29/05/2025 America/Toronto Pharma & Biotech Patent Litigation in Europe Pharma & Biotech Patent Litigation in Europe
May 28 – 29, 2025
Amsterdam
Please visit https://www.c5-online.com/pharma-biotech-patent-litigation/ for more information and updates. Amsterdam true DD/MM/YYYY 1440 use-title -
-
-
28/05/2025 29/05/2025 America/Toronto Pharma & Biotech Patent Litigation in Europe Pharma & Biotech Patent Litigation in Europe
May 28 – 29, 2025
Amsterdam
Please visit https://www.c5-online.com/pharma-biotech-patent-litigation/ for more information and updates. Amsterdam true DD/MM/YYYY 1440 use-title -
Our 2024 event has concluded. Thank you to those who joined us in Amsterdam!
Stay tuned for more information about our upcoming event. We look forward to bringing you another exceptional conference next year and look forward to returning in May 2025!
OUR 2025 PROGRAM IS IN DEVELOPMENT
2024 CONFERENCE CHAIRS
Joel Coles
Partner
Powell Gilbert LLP
Rachel Mumby
Partner
Bristows LLP
Ruud van der Velden
Partner
Hogan Lovells
2024 UPC SPEAKERS
Honorable András Kupecz
Legally Qualified Judge, Central Division, Munich Section
Unified Patent Court
Honorable Edger Brinkman
Legally Qualified Judge, Local Division, The Hague
Unified Patent Court
Honorable Marije Knijff
District Court Judge
The Hague
Prof. Willem Hoyng
Partner
Hoyng Rokh Monegier
Chairman of the UPC Advisory Committee
(Moderator)
2024 IN-HOUSE COUNSEL SPEAKERS
Frank Landolt
Chief Counsel, IP and Legal
Confo Therapeutics
Julia Pike
Global IP Head
Sandoz
Karin Pramberger
Head of IP
Swiss Pharma International AG
Jiri Slavik
Director, IP
Adalvo
Brigitte Carion-Taravella
Principal Patent Counsel, Lead Biologics IP EU
Global IP Department, Legal, Ethics & business Integrity
Sanofi
Shohta Ueno
Senior Director, Assistant General Counsel – Dispute Resolution
Regeneron
2024 EVENT HIGHLIGHTS
Engage with Industry Pioneers: Featuring a judicial roundtable with Honorable Rian Kalden, András Kupecz, and Edger Brinkman, alongside leading Chief IP Counsel insights, this conference is a hub for high-level intellectual exchange within the European life sciences patent elite
Master the UPC’s Evolving Terrain: Obtain key judicial insights, shedding light on the UPC’s initial impact, procedural details, and strategic influence on European patent litigation
Unravel Regulatory Transformations: Explore the EU’s legislative transformation and see how new directives and regulations are reshaping pharma and biotech litigation strategies
Strategize Across Borders: Sharpen your cross-border litigation strategies with sessions on defending patent rights outside the UPC, navigating China’s patent linkage system, and understanding crucial U.S. legal developments, facing global challenges head-on
C5’S 17 YEAR IMPACT AT PHARMA & BIOTECH EUROPE
1000+
Attendees
330+
Speakers
60+
Sponsors
36
Countries in Attendance
DISTINGUISHED FACULTY
The best that the bar, the bench, and the industry have to offer
MASTER LEVEL STRATEGIES
For litigators and in-house counsel
UNPARALLELED CONNECTIONS
With the “Who’s Who” of the European Life Sciences Patent Bar
ABOUT THIS CONFERENCE
C5’s Forum on Pharma & Biotech Patent Litigation in Europe will help you understand the latest legal advancements and regulatory developments in the field, offering insights for both litigators and in-house counsel. Attendees can look forward to engaging sessions that explore the evolving implications of the Unified Patent Court (UPC), unpack the nuances of international patent litigation, and unravel the complexities of the EU’s regulatory transformations.
Our event is designed to highlight the most current challenges and opportunities, including in-depth discussions on the doctrine of equivalents, preliminary injunction proceedings, and global strategies for biosimilars and biologics, the conference is set to be a key convergence point for the who’s who of the European life sciences patent bar. Join us to connect, learn, and shape the future of pharma and biotech patent litigation.
WHO SHOULD ATTEND
In-Housel Counsel and Executives from Pharmaceutical and Biotech Companies, including:
- Head of IP
- Head of Patent Litigation
- VP-Intellectual property
- Scientific Director
- Head of Legal / Legal Affairs
- Principal Patent Examiner
- Head of Global Strategy
- Director Innovation, IP and Portfolio Management
- R&D Patent manager
- Associate VP & Director of Technology Licensing & Commercialization
- Patent Counsel
Law firm attorneys with practices in:
- Intellectual Property and Patent Law
- Life Sciences
- European Patent Law
- US Patent
OUR PRIOR DELEGATES SAY IT BEST
The combination of networking opportunities with people from various backgrounds. Concise overview over the most relevant topics.
Good networking opportunities with in-house Counsel and leading IP law firms. Hot topics, great speakers and convenient number of attendants.
Important subject matters to discuss presented by renowned specialists. An important conference to attend.
